Clinical trial

Dexmedtomodine Effect on Agitated Psychotic Patients Suffer COPD

NCT06567587

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2024-06-10

PhaseN/A

Study timeline

Study start (actual)2024-06-10Date precision: day

Registry last updated2026-01-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Response of Agitated Patients to Dexmedetomidineunresolved

Interventions

DexmedetomidineDRUG · verified · RxNorm: dexmedetomidine

BIPAPDEVICE

Sponsors & collaborators

Tanta Universitylead sponsor

Laila Ahmed Abd-Elmotaleb El-Ahwalcollaborator

Marwa Ahmed Abogabalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06567587 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.